T1	Participants 40 114	primary breast cancer patients: a randomized prospective multicenter trial
T2	Participants 242 272	primary breast cancer patients
T3	Participants 325 351	highly distressed patients
T4	Participants 458 657	Three hundred and fifty-three women within one year of diagnosis with primary breast cancer were randomly assigned to receive supportive-expressive group therapy or to an education control condition.
T5	Participants 658 842	Participants were recruited from two academic centers and nine oncology practices, which were members of NCI's Community Clinical Oncology Program (CCOP) and were followed over 2 years
T6	Participants 1091 1114	Highly distressed women
T7	Participants 1390 1422	women with primary breast cancer
T8	Participants 1467 1511	women with higher initial levels of distress
